Building better recovery care through pharmacy partnerships
Australians affected by alcohol and other drug use often need support that fits around ordinary life: collecting a prescription after work, asking a pharmacist about sleep, or finding treatment while caring for family. Community pharmacies are accessible across Melbourne, Sydney, regional centres and rural communities, while Certified Recovery Specialists can add lived experience and continuing peer support. A collaborative care model connects these strengths without asking either profession to work beyond its competence.
Pharmacists contribute medication knowledge, early risk identification and reliable follow-up. Certified Recovery Specialists contribute trust, practical recovery guidance and insight into barriers that clinical records may miss. The aim is coordinated care, not a transfer of responsibility: the pharmacist supports safe medication use, the specialist supports engagement and recovery goals, and both respond early when needs change.
A workable model needs agreement on referrals, consent, privacy, escalation and feedback. It also needs time built into paid work, clear boundaries and measures that matter to the person receiving care. The model should be adapted for each pharmacy, community and service setting, including regional areas where travel and limited after-hours support can shape what is realistic.
Define the partnership around shared goals
Begin with the goals defined by the person seeking support. Recovery may involve reducing or stopping a substance, stabilising physical health, rebuilding relationships, finding accommodation, managing pain or regaining control over daily routines. A pharmacist’s priorities may centre on medication safety, while a Certified Recovery Specialist may focus on confidence, housing or connection with support networks. Both priorities belong in the shared plan.
Define each role before care begins. Pharmacists remain responsible for clinical advice within their professional scope, medicine supply, medication reconciliation and identifying medicine-related harm. Recovery specialists support recovery goals, offer peer guidance and help people navigate services without presenting themselves as clinicians. They can also flag changes in mood, engagement or safety and agree how these observations should be communicated.
Shared principles should include respect, privacy, non-stigmatising language and the right to change goals. Cultural safety requires more than general awareness. Where relevant, the partnership should work with Aboriginal and Torres Strait Islander community-controlled services and local cultural protocols. Family members or Aboriginal health workers may also have an important role, but their involvement should follow the individual’s consent and preferences.
Map referrals and the patient journey
Community pharmacies often encounter recovery needs before they become visible to specialist services. A person may request a repeat medicine, buy an over-the-counter product for anxiety, ask about naloxone or disclose increased alcohol use during a medication review. These encounters create opportunities for a private conversation, a consented referral or a connection with a recovery specialist.
Build referral routes that fit the Australian health system. Entry points can include general practitioners, alcohol and other drug services, emergency departments, community mental health teams, disability supports and self-referral. Medicare and the Pharmaceutical Benefits Scheme shape access to subsidised treatment, while bulk-billed appointments and prescription co-payments affect whether a person can continue a care plan. Clear information about costs prevents medication changes caused by financial pressure.
Use a warm handoff wherever possible. The pharmacist can call the recovery specialist, explain the reason for referral with the patient’s permission and arrange a contact time. If direct contact is not appropriate, provide a simple referral card containing the specialist’s role, hours, phone number and preferred communication method. Record whether the offer was accepted, declined or deferred, then arrange another check-in rather than allowing an unsuccessful referral to disappear.
Make communication and information sharing work
Short, structured team huddles can prevent fragmented care. A weekly or fortnightly meeting works for many partnerships, while smaller services might use a monthly case review supported by secure messages. SBAR is a useful format: situation, background, assessment and recommendation. It gives each professional a concise way to share observations and make a clear request, especially when a decision is needed from a prescriber or service coordinator.
Information sharing should follow privacy obligations under applicable federal and state or territory laws. Electronic prescriptions and My Health Record can improve continuity, although access depends on identity verification and clinical permissions. The partnership should agree which information is relevant, who can view it and how long it is retained. The person receiving care should know when information will be exchanged between organisations and how to ask questions about access or correction.
| Care element | Community pharmacist | Certified Recovery Specialist | Shared workflow |
|---|---|---|---|
| First contact | Review medicines, allergies, supplements and immediate safety concerns | Identify goals, preferences, recovery strengths and practical barriers | Obtain consent and agree the first priority |
| Medication support | Check interactions, interactions with alcohol, dosing and adverse effects | Identify adherence barriers and support follow-up routines | Update the shared care plan and communicate changes |
| Continuing care | Monitor prescriptions, supply, withdrawal risk and medicine safety | Provide peer support, relapse planning and links to community resources | Review progress and decide whether escalation is needed |
| Urgent concerns | Recognise and act on overdose, severe withdrawal or other clinical danger | Notice significant changes and remain within the agreed role | Follow the shared emergency and escalation pathway |
The shared care plan should be brief enough to use during a busy pharmacy shift. Include agreed goals, contact preferences, medication-related actions, warning signs, escalation routes and the date of the next review. Both professionals should document their own actions and flag disagreements early. A disagreement about treatment priority can be resolved through supervision, a general practitioner review or a joint conversation with the person receiving care.
Support medicines, harm reduction and relapse
Medication review is a central part of the partnership. Pharmacists can identify duplicate medicines, interactions, unsafe combinations and missed medicines that may cause withdrawal. Opioids mixed with alcohol, benzodiazepines or other sedatives require careful discussion, with advice based on the individual’s treatment plan. Opioid treatment medicines such as methadone or buprenorphine must be supplied under applicable national program requirements and state or territory arrangements.
Harm reduction provides practical protection while recovery goals develop. A pharmacist can discuss naloxone, where it can be obtained, how to store it and how to use it with a family member or support person. Where permitted, take-home naloxone and safe medicine storage or disposal can be incorporated into care. A missed dose or change in substance use should prompt review, not shame. Early contact may prevent an unplanned overdose, severe withdrawal or avoidable treatment interruption.
Escalation plans should be simple enough to use under stress. If there is immediate danger, call 000. Lifeline provides confidential support on 13 11 14, while the Poison Information Centre can assist with medicine exposure on 13 20 45. Recovery specialists should know when emergency assistance is required and how to support contact without delaying urgent care. Pharmacists should know which community crisis and alcohol or other drug services operate after hours.
Pain can complicate recovery and medication reviews. When someone reports neuropathic pain after shingles, the pharmacist can review analgesic options and discuss current Australian guidance. A patient may also use a resource on zoster treatment information as background, while the pharmacist confirms that its clinical claims are current and suitable. Relapse planning should cover triggers, early warning signs, medication access, support contacts and a rapid route back to care.
Train and supervise the partnership safely
Training should prepare both professions for the realities of the partnership. Pharmacists can practise brief screening, motivational conversations, trauma-informed care, suicide prevention and local referral pathways. Recovery specialists need a clear understanding of medication safety, adverse effects, professional boundaries, escalation and the limits of peer support. The Certified Recovery Specialist title does not represent a national statutory registration, so employers should verify the issuing body, competency requirements, supervision and recertification process.
Clinical responsibilities remain governed by professional and legislative requirements. Pharmacists should work within the Pharmacy Board of Australia’s Code of Conduct for Pharmacists and relevant requirements of the National Health Act 2011. Opioid treatment, supply of poisons and some mental health practices also depend on state and territory legislation and the current Supply Poisons Standard. Privacy duties under the Privacy Act 1988, where applicable, and relevant health-records laws must guide information sharing.
Supervision creates a place to discuss difficult cases and prevent role confusion. A monthly reflective session can examine whether referrals were timely, whether consent remained clear and whether either professional felt pressured to act outside their scope. A practitioner perspective can support that wider discussion of professional reflection, while local supervision remains the source of feedback and accountability. Measures should include referral completion, continuity of care, medicine safety, service access and feedback from people receiving support.
Establish a durable pathway to action
Start with a defined pilot involving one community pharmacy and one Certified Recovery Specialist. Agree how referrals will be made, which information can be shared, when the team will meet and how urgent concerns will escalate. Test the pathway with a small number of consenting participants, review the experience after several weeks and revise the workflow before expanding. Protect paid time for case reviews so that collaboration does not depend on goodwill after the initial enthusiasm fades.
Explore sustainable funding through Primary Health Networks, state and territory alcohol and other drug funding, commissioned community services and eligible National Disability Insurance Scheme supports. Medicare remains important for general practice and prescribed treatment, while pharmacy services need funding for coordination, follow-up and training. The partnership should also account for pharmacy workflow, staff turnover, specialist availability and the digital access needs of people in regional, rural and remote communities.
Contact a local community pharmacy and invite a Certified Recovery Specialist to establish a referral pathway, a regular review time and a shared escalation plan. Give each participating professional a clear role, document consent, and ask people receiving care how the service should improve. A stronger recovery system begins with an accessible first contact, a respectful conversation and a practical next step that both professions can support.